EXC 001

DRUG4 trials

Sponsors

Pfizer

Conditions

Reduction in Hypertrophic Skin ScarringScar Prevention

Phase 2

Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

CompletedNCT01038297

PfizerScar Prevention

Start: 2009-12-01End: 2010-07-07Updated: 2021-09-20

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

CompletedNCT01037413

PfizerScar Prevention

Start: 2009-12-22End: 2010-04-09Updated: 2021-08-02

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

CompletedNCT01037985

PfizerScar Prevention

Start: 2009-12-03End: 2010-09-22Updated: 2021-08-02

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

CompletedNCT01346969

PfizerReduction in Hypertrophic Skin Scarring

Start: 2011-06-01End: 2012-04-16Updated: 2021-09-09